Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01077024 · ClinicalTrials.gov registry record · Phase 3
Smoking-Cessation and Stimulant Treatment (S-CAST)
A Phase 3 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 538
- Enrollment target
NCT01077024 is a Phase 3 study that has completed, run by University of Cincinnati. The registered enrollment target is 538 participants.
The verdict
NCT01077024, a Phase 3 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 538 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the impact of substance-abuse treatment as usual plus smoking-cessation treatment (TAU+SCT), relative to substance-abuse treatment as usual (TAU), on drug-abuse outcomes. Specifically, this study will evaluate whether concurrent smoking-cessation treatment improves, worsens, or has no effect on stimulant-use outcomes in smokers who are in outpatient substance-abuse treatment for cocaine or methamphetamine dependence.
Interventions
- OTHER Smoking-cessation treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 538 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01077024
The ClinicalTrials.gov registry entry for NCT01077024 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 538 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smoking-cessation treatment is the first listed.
NCT01077024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01077024 about?
NCT01077024 is a clinical study titled "Smoking-Cessation and Stimulant Treatment (S-CAST)". The primary objective of this study is to evaluate the impact of substance-abuse treatment as usual plus smoking-cessation treatment (TAU+SCT), relative to substance-abuse treatment as usual (TAU), on drug-abuse outcomes. Specifically, this study will evaluate whether concurrent smoking-cessation tr...
What is the current status of trial NCT01077024?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 538 participants. The study started on 2010-02. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01077024?
The interventions under investigation include: Smoking-cessation treatment (OTHER).
Who is sponsoring clinical trial NCT01077024?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.